Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Multiparameter Immunochromatographic Assay Detects and Differentiates Hepatitis C Antibodies

By LabMedica International staff writers
Posted on 14 Aug 2013
A hepatitis C (HCV) rapid test has been developed that should provide additional information about the infection profile.

The Multisure HCV antibody assay is a qualitative, multiparameter, immunochromatographic assay, intended for the detection and differentiation of Hepatitis C antibodies that may be present in patients with acute or chronic Hepatitis C infection. More...
The test was developed based on the patented reverse-flow technology, giving greater sensitivity and stronger visual signals.

Developed by MP Diagnostic (Solon, OH, USA), the Multisure HCV antibody assay uses human whole blood, plasma, or serum. It has a short test-time and can detect and differentiate HCV antibodies against both structural and non-structural proteins across all six genotypes. The assay is instrument free, easy to use, and is suitable for use at Point-of-Care (POC) or with automation. It does not require highly trained personnel to perform the test. It has shown excellent correlation with polymerase chain reaction (PCR), enzyme immunoassay (EIA), and Immunoblot.

MP Biomedicals received the CE marking for its new, multiparameter Hepatitis C test.

Related Links:

MP Diagnostic



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Pipette Calibration System
Artel PCS®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The model estimated about a fivefold return in gastric cancer prevention benefits per unit invested, with cost-effectiveness maintained in higher-cost settings (Image credit: Adobe Stock)

H. pylori Screening Within Colorectal Program Aids Gastric Cancer Prevention

Health systems increasingly rely on economic evidence to guide cancer prevention strategies. For gastric cancer, selecting screening approaches that can integrate with existing programs is a key policy question.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.